Isis Pharma calls-off development of rheumatoid arthritis drug
Isis Pharmaceuticals Inc. said it will discontinue development of its experimental rheumatoid arthritis drug following poor Phase…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.